ES
UTHR icon

Element Squared’s United Therapeutics UTHR Stock Holding History

Element Squared’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Sell
4,240
-787
-16% -$392K 1.42% 7
2025
Q4 		$2.45M Buy
+5,027
New +$2.34M 1.33% 21

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Element Squared's UTHR Position: Q1 2026 in Review

Element Squared reduced its United Therapeutics (UTHR) stake by 16% in Q1 2026, selling an estimated $392K and leaving 4,240 shares worth $2.51M. The position accounts for 1.42% of the portfolio, ranked #7.

Element Squared first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Element Squared held 4,240 shares of United Therapeutics worth $2.51M as of Q1 2026.
  • Element Squared sold 787 United Therapeutics shares in Q1 2026, an estimated $392K.
  • United Therapeutics made up 1.42% of Element Squared's portfolio in Q1 2026, its #7 holding.
  • Element Squared first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Element Squared's 13F filing for Q1 2026, filed 23 Apr 2026.